Lucas Luiz de Lima Silva

Lucas Luiz de Lima Silva

Auto-generated profile, based on publicly available information

Lucas Luiz de Lima Silva

Universidade Federal de Goiás, Brasil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2017 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
RGRodrigo Saar Gomes
Rodrigo Saar Gomes
MSMuriel Vilela Teodoro Silva
Muriel Vilela Teodoro Silva
JSJéssica Cristina dos Santos
Jéssica Cristina dos Santos
LSLucas Luiz de Lima Silva
Lucas Luiz de Lima Silva
ABAline Carvalho Batista
Aline Carvalho Batista
FRFátima Ribeiro-Dias
Fátima Ribeiro-Dias
Interleukin 32 (IL-32) is a pro-inflammatory cytokine induced in patients with American tegumentary leishmaniasis (ATL) caused by Leishmania braziliensis. Here, we investigated whether IL-32 is also expressed in patient lesions caused by L. amazonensis. In addition, we evaluated experimental L. amazonensis and L. braziliensis infections in C57BL/6 transgenic mice for human IL-32γ (IL-32γTg) in comparison with wild-type (WT) mice that do not express the IL-32 gene. Human cutaneous lesions caused by L. amazonensis express higher levels of IL-32 than healthy control skin. In mice, the presence of IL-32γ promoted the control of cutaneous lesions caused by L. braziliensis, but not lesions caused by L. amazonensis in an ear dermis infection model. In addition, IL-32γTg mice displayed less tissue parasitism and inflammation in IL-32γTg than WT mice during the healing phase of L. braziliensis infection. Production of antigen-specific pro-inflammatory cytokines was higher in IL-32γTg mice than in WT mice during L. braziliensis infection but not during L. amazonensis infection. Human cutaneous lesions caused by L. amazonensis express high levels of IL-32. In mice, the presence of IL-32γ contributes to the lesion healing caused by L. braziliensis but not by L. amazonensis. Data suggest that despite the ability for both species to induce IL-32 in humans, the connections between this cytokine and other immune players induced by related species of parasites can lead to distinct outcomes of the murine infections.

1 October 2021 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
AOAna Karoline Silva Oliveira
Ana Karoline Silva Oliveira
LSLucas Luiz de Lima Silva
Lucas Luiz de Lima Silva
MMMarina Pacheco Miguel
Marina Pacheco Miguel
ABAngel José Vieira Blanco
Angel José Vieira Blanco
LCLilian Carla Carneiro
Lilian Carla Carneiro
MBMônica Santiago Barbosa
Mônica Santiago Barbosa
BACKGROUND: Helicobacter pylori colonizes approximately half of the world’s human population. Its presence in the gastric mucosa is associated with an increased risk of gastric adenocarcinoma, gastric lymphoma, and peptic ulcer disease. In Brazil, the high prevalence of H. pylori infection is a serious health problem. H. pylori virulence factors are associated with an increased risk of serious gastrointestinal disorders. The cagA gene encodes a cytotoxin-A-associated antigen (CagA) that is involved in bacterial pathogenicity. H. pylori strains carrying the cag pathogenicity island (cag-PAI) are significantly associated with severe clinical outcomes and histopathological changes. OBJECTIVE: The present study aims to investigate the prevalence of the cagA gene among H. pylori isolates from patients with different gastric pathologies. Further, the study hopes to verify its association with clinical outcomes. In addition, phylogenetic analysis was performed on cagA-positive H. pylori strains from patients with severe and non-severe diseases. METHODS: Gastric specimens were collected through a biopsy from 117 patients with different esogastroduodenal diseases. DNA was extracted from these gastric specimens and the polymerase chain reaction was performed to amplify the gene fragments corresponding to the 16S ribosomal RNA and cagA genes using specific primers. The polymerase chain reaction products of selected samples positive for cagA were sequenced. The sequences were aligned with reference sequences from the National Center for Biotechnology Information (NCBI) (Bethesda/USA), and a phylogenetic tree was constructed. RESULTS: H. pylori was detected in 65.9% (77/117) of Brazilian patients with different gastroduodenal disorders. Overall, 80.5% (62/77) of the strains were cagA-positive. The ages of patients with cagA-positive strains (15 males and 47 females) ranged from 18 to 74 years. The lesions were categorized as non-severe and severe according to the endoscopic and histopathological reports the most prevalent non-severe esogastroduodenal lesion was gastritis 54/77 (70.12%), followed by esophagitis 12/77 (15.58%) and duodenitis 12/77 (15.58%). In contrast, the most prevalent severe lesions were atrophy 7/77 (9.09%), followed by metaplasia 3/77 (3.86%) and gastric adenocarcinoma 2/77 (2.59%). Phylogenetic analyses performed with the partial sequences of the cagA gene obtained from local strains were grouped in the same clade. No differences in phylogenetic distribution was detected between severe and non-severe diseases. CONCLUSION: The cagA gene is highly prevalent among H. pylori isolates from gastric lesions in Brazilian patients. The presence of the cagA gene was not considered a marker of the severity of esogastroduodenal lesions in the present study. This is the first study to investigate the phylogenetic population structure of H. pylori strains in a Brazilian capital, which may improve our understanding of the clinical outcome of H. pylori infection.

1 May 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
GMGrazzielle Guimarães Matos
Grazzielle Guimarães Matos
AFAna Marina Barroso de Figueiredo
Ana Marina Barroso de Figueiredo
PGPedro Hugo Diniz Gonçalves
Pedro Hugo Diniz Gonçalves
LSLucas Luiz de Lima Silva
Lucas Luiz de Lima Silva
ABAline Carvalho Bastista
Aline Carvalho Bastista
FRFátima Ribeiro-Dias
Fátima Ribeiro-Dias

1 January 2024 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
DMDiogo Nery Maciel
Diogo Nery Maciel
LSLucas Luiz de Lima Silva
Lucas Luiz de Lima Silva
LALeandro Do Prado Assunção
Leandro Do Prado Assunção
LRLucas Rasmussen
Lucas Rasmussen
MBMônica Santiago Barbosa
Mônica Santiago Barbosa
Helicobacter pylori is an etiologic agent of gastroduodenal diseases. The microorganism, considered a type I carcinogen, affects about 50% of the global population. H. pylori virulence factors are determinant for the clinical outcome of the infection. The outer inflammatory protein A (oipA) gene encodes an outer membrane adhesin and is related to severe gastropathies, such as gastric cancer.

28 August 2019 in Arquivos de Ciências da Saúde
Verified
Journal Article
Open access
PDF file
AFAna Claudia Goulart Ferreira
Ana Claudia Goulart Ferreira
XPXisto Sena Passos
Xisto Sena Passos
MJMilton Camplesi Junior
Milton Camplesi Junior
JMJuliana Menara De Souza Marques
Juliana Menara De Souza Marques
LSLucas Luiz De Lima Silva
Lucas Luiz De Lima Silva
Introdução: O sistema complemento é composto por diversas proteínas plasmáticas e é um importante mecanismo de defesa da imunidade inata e adquirida, que exerce funções homeostáticas e fisiológicas, como a remoção de células apoptóticas e complexos imunes. A deficiência neste mecanismo pode ser hereditária ou adquirida, e leva ao aumento da susceptibilidade a doenças infecciosas e não infecciosas, raras e fatais. Objetivo: Descrever as principais causas e consequências da deficiência do sistema complemento e relacioná-las com múltiplas patologias. Material e Métodos: Trata-se de uma revisão bibliográfica narrativa, tendo como base de dados, artigos publicados no Scientific Electronic Library Online (SciELO), National Library of Medicine (PubMed), Medical Literature Analysis and retrieval System Online (MEDLINE), nos últimos 5 anos. Resultados: A associação do complemento e doenças foram observadas em situações de deficiência do sistema complemento, anormalidades na regulação e nas inflamações. Mutações genéticas ou aumento do consumo do complemento levam à ativação imprópria ou excessiva do complemento, podendo conduzir a consequências lesivas e ao desenvolvimento de diversas doenças, como, lúpus eritematoso sistêmico, síndrome urêmica hemolítica atípica, glomerulopatia C3, hemoglobinúria paroxística noturna, glomerulonefrite pósinfecciosas, artrite reumatoide, dentre outras. Conclusão: É evidente a participação do sistema complemento na patogênese e patogenia de diversas doenças. O investimento em pesquisas, que visem ampliar o entendimento do papel do mecanismo do sistema complemento, pode contribuir para o desenvolvimento de intervenções terapêuticas paliativas e ou de cura de diversas doenças, com a consequente melhoria da qualidade de vida dos indivíduos acometidos.